Elite Clinical Laboratory

Introducing Our New Testing Services - Hereditary ENT Disorders Testing | Expanded Coverage: Now Serving More States - Call to know more.

Respiratory Pathogen Panel

Targeted panel testing for multi-pathogen detection

Introduction

Rapid Respiratory Pathogen Detection

Rapid Respiratory Pathogen Detection The Respiratory Pathogen Panel is a molecular diagnostic test that simultaneously identifies viral and bacterial nucleic acids (DNA or RNA) from a wide range of respiratory pathogens using a single patient sample, typically collected via nasopharyngeal swab. This approach enables rapid, accurate detection of multiple organisms—such as influenza, RSV, SARS-CoV-2, and atypical bacteria—helping clinicians differentiate causes of respiratory illness and tailor treatment decisions quickly and effectively.

Why the Test Is Significant​

Rapid Diagnosis

Get results often within hours for timely, targeted treatment

Antibiotic Stewardship

Helps reduce unnecessary antibiotic use and resistance risks

Enhanced Infection Control

Supports rapid containment in hospitals and shared settings

Public Health Surveillance

Tracks key pathogens like Flu, RSV, and COVID-19

Unknown and Interesting Facts

Respiratory co-infections—where multiple pathogens are present simultaneously—are more common than often assumed, particularly in pediatric, elderly, or immunocompromised populations. Multiplex molecular panels like RPP can detect viral and bacterial pathogens in one test, including those that are difficult or slow to culture, such as RSV or atypical bacteria. Rapid and accurate detection of co-infections supports appropriate isolation, reduces unnecessary antibiotic use, and enables more precise clinical decision-making.

Medical Necessity and Signs/Symptoms

  • Moderate to severe respiratory symptoms (fever, cough, congestion)
  • Shortness of breath or difficulty breathing
  • Sore throat, sinus pressure, or nasal discharge
  • High-risk individuals (infants, elderly, immunocompromised)
  • Outbreak investigations in clinical or community settings
  • Suspected flu, RSV, COVID-19, or atypical pneumonia
  • Hospitalized patients requiring immediate diagnostic clarification
  • Cases where rapid pathogen identification impacts treatment

Post-Test Support

Elite Clinical Laboratory delivers RPP results with rapid turnaround and clinically actionable clarity. Our reports list all detected pathogens in an easy-to-read format and highlight co-infection scenarios that may affect treatment planning. We also offer interpretation support to guide clinicians in choosing appropriate therapies, adjusting infection control measures, and avoiding unnecessary interventions based on a complete pathogen profile.

Our Documentation